Predicting Brain Tumor Response to Therapy using a Hybrid Deep Learning and Radiomics Approach

Fuente: arXiv
Saved in:
Bibliographic Details
Main Authors: Tikhonov, Daniil, Scatolin, Matheus, Banerjee, Mohor, Ji, Qiankun, Jaheen, Ahmed, Salem, Mostafa, Elsayed, Abdelrahman, Wang, Hu, Hashmi, Sarim, Yaqub, Mohammad
Format: Preprint
Published: 2025
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866911142698287104
author Tikhonov, Daniil
Scatolin, Matheus
Banerjee, Mohor
Ji, Qiankun
Jaheen, Ahmed
Salem, Mostafa
Elsayed, Abdelrahman
Wang, Hu
Hashmi, Sarim
Yaqub, Mohammad
author_facet Tikhonov, Daniil
Scatolin, Matheus
Banerjee, Mohor
Ji, Qiankun
Jaheen, Ahmed
Salem, Mostafa
Elsayed, Abdelrahman
Wang, Hu
Hashmi, Sarim
Yaqub, Mohammad
contents Accurate evaluation of the response of glioblastoma to therapy is crucial for clinical decision-making and patient management. The Response Assessment in Neuro-Oncology (RANO) criteria provide a standardized framework to assess patients' clinical response, but their application can be complex and subject to observer variability. This paper presents an automated method for classifying the intervention response from longitudinal MRI scans, developed to predict tumor response during therapy as part of the BraTS 2025 challenge. We propose a novel hybrid framework that combines deep learning derived feature extraction and an extensive set of radiomics and clinically chosen features. Our approach utilizes a fine-tuned ResNet-18 model to extract features from 2D regions of interest across four MRI modalities. These deep features are then fused with a rich set of more than 4800 radiomic and clinically driven features, including 3D radiomics of tumor growth and shrinkage masks, volumetric changes relative to the nadir, and tumor centroid shift. Using the fused feature set, a CatBoost classifier achieves a mean ROC AUC of 0.81 and a Macro F1 score of 0.50 in the 4-class response prediction task (Complete Response, Partial Response, Stable Disease, Progressive Disease). Our results highlight that synergizing learned image representations with domain-targeted radiomic features provides a robust and effective solution for automated treatment response assessment in neuro-oncology.
format Preprint
id arxiv_https___arxiv_org_abs_2509_06511
institution arXiv
publishDate 2025
record_format arxiv
spellingShingle Predicting Brain Tumor Response to Therapy using a Hybrid Deep Learning and Radiomics Approach
Tikhonov, Daniil
Scatolin, Matheus
Banerjee, Mohor
Ji, Qiankun
Jaheen, Ahmed
Salem, Mostafa
Elsayed, Abdelrahman
Wang, Hu
Hashmi, Sarim
Yaqub, Mohammad
Computer Vision and Pattern Recognition
Accurate evaluation of the response of glioblastoma to therapy is crucial for clinical decision-making and patient management. The Response Assessment in Neuro-Oncology (RANO) criteria provide a standardized framework to assess patients' clinical response, but their application can be complex and subject to observer variability. This paper presents an automated method for classifying the intervention response from longitudinal MRI scans, developed to predict tumor response during therapy as part of the BraTS 2025 challenge. We propose a novel hybrid framework that combines deep learning derived feature extraction and an extensive set of radiomics and clinically chosen features. Our approach utilizes a fine-tuned ResNet-18 model to extract features from 2D regions of interest across four MRI modalities. These deep features are then fused with a rich set of more than 4800 radiomic and clinically driven features, including 3D radiomics of tumor growth and shrinkage masks, volumetric changes relative to the nadir, and tumor centroid shift. Using the fused feature set, a CatBoost classifier achieves a mean ROC AUC of 0.81 and a Macro F1 score of 0.50 in the 4-class response prediction task (Complete Response, Partial Response, Stable Disease, Progressive Disease). Our results highlight that synergizing learned image representations with domain-targeted radiomic features provides a robust and effective solution for automated treatment response assessment in neuro-oncology.
title Predicting Brain Tumor Response to Therapy using a Hybrid Deep Learning and Radiomics Approach
topic Computer Vision and Pattern Recognition
url https://arxiv.org/abs/2509.06511